[Skip to Content]
[Skip to Content Landing]
Other Articles
January 21, 1961

Oral Contraception

JAMA. 1961;175(3):225-226. doi:10.1001/jama.1961.63040030001009

WITH THE RECENT decision of the Food and Drug Administration approving the use of norethynodrel, a synthetic, progesterone-like compound, for the cyclic inhibition of ovulation, oral contraception has become an accomplished fact. While the new ruling limits the prescription of the hormone for any individual to a two-year period, this amount of time obviously is adequate for many individuals who are planning their families.

Of considerable interest, in the brief time that norethynodrel contraception has been accepted, is the mixed reaction on the part of practicing physicians. Many have been enthusiastic about the availability of a "pill" form of contraception, while others have been either indifferent or extremely skeptical. Some consider the use of a constitutional approach to birth control too radical and one that may be associated with hidden problems. These reactions are of course separate from those of a substantial number of physicians who, for religious or other

First Page Preview View Large
First page PDF preview
First page PDF preview